THE OFFICIAL
ONLY FROM REDWOOD MEDIA
Hover over a menu item to access other pages
A RATING
Mayya Yukilevich
Chief Business Development Officer, CloudCath
Few leaders in healthcare bring the depth of perspective and drive for disruption that Mayya Yukilevich does. With 17 years of experience in the healthcare industry—most of it spent navigating the complex world of dialysis—she has built a reputation as both a strategist and a visionary. Her expertise stretches across every stage of the patient journey, from the first nephrologist visit to the life-altering transition to dialysis, giving her an unmatched understanding of where patients often fall through the cracks. It’s this clarity that fuels her work at CloudCath, where she is helping to revolutionize the way catheter-based treatments are monitored.
Mayya’s career is a study in leadership through impact. At Fresenius Medical Care, she spent a decade mastering the operational intricacies of dialysis. Later, at U.S. Renal Care, she spearheaded growth through joint ventures and M&A, proving her ability to not only scale businesses, but also reshape markets. With a master’s degree in economics and specialties ranging from market access to value-based care, she stands at the crossroads of patient advocacy and business innovation—a place where she thrives.
CloudCath, founded in 2017 in San Francisco, is far from a conventional MedTech company. Its remote monitoring platform is the first of its kind to detect signs of infections in peritoneal dialysis patients before symptoms even appear. The company’s flagship device, cleared by the FDA in 2022 and now in use nationwide, analyzes drainage fluid in real time with proprietary algorithms. If early warning signs emerge, the system instantly alerts healthcare teams—giving physicians a critical three-day window to intervene before patients feel ill. In an arena where peritonitis is one of the leading causes of hospitalization and treatment dropout, those three days can mean the difference between preserved quality of life and a devastating decline.
But CloudCath is not just about cutting-edge technology—it’s about people. Alongside its smart sensor, the company deploys success managers who work directly with patients and physicians, ensuring seamless communication and faster action when complications arise. This blend of digital health innovation and human support makes CloudCath a lifeline for patients and a game-changer for clinicians.
For Mayya, this is not just business—it’s personal. “What we’re doing is revolutionary for the industry,” she says, “and it’s finally solving challenges that have existed in dialysis for decades.” Her conviction is backed by results: peritoneal dialysis, long touted as the patient-friendly and cost-effective alternative to hemodialysis, has struggled with high attrition rates due to infection. CloudCath offers a solution that could finally shift the balance, helping more patients stay on the treatment that preserves their independence, their health, and their lives.
With Mayya Yukilevich driving business development, CloudCath is more than a company—it’s a movement to redefine renal care. Under her leadership, innovation meets execution, and the result is nothing short of transformative for patients, providers, and the future of healthcare.
Mayya Yukilevich
Chief Business Development Officer
CloudCath
Website: www.cloudcath.com